Aripiprazole for the treatment of schizophrenia with co occurring social anxiety / Robert G. Stern en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 206-209 Título : Aripiprazole for the treatment of schizophrenia with co occurring social anxiety : An open label cross taper study Tipo de documento: texto impreso Autores: Robert G. Stern, Autor ; Theodore A. Petti, Autor ; Kurt Bopp, Autor Fecha de publicación: 2022 Artículo en la página: pp. 206-209 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Concurrente, Ansiedad social, Aripiprazol Resumen: Co-occurring social anxiety in patients with schizophrenia is common and often severe. Pharmacologic agents with serotonin receptor 1A agonist properties such as aripiprazole are believed to be effective anxiolytic drugs. Link: ./index.php?lvl=notice_display&id=29499 [artículo] Aripiprazole for the treatment of schizophrenia with co occurring social anxiety : An open label cross taper study [texto impreso] / Robert G. Stern, Autor ; Theodore A. Petti, Autor ; Kurt Bopp, Autor . - 2022 . - pp. 206-209. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 206-209 Palabras clave: Esquizofrenia, Concurrente, Ansiedad social, Aripiprazol Resumen: Co-occurring social anxiety in patients with schizophrenia is common and often severe. Pharmacologic agents with serotonin receptor 1A agonist properties such as aripiprazole are believed to be effective anxiolytic drugs. Link: ./index.php?lvl=notice_display&id=29499

---

1 (1 - 1 / 1)